|
|
Volumn 51, Issue 1, 2001, Pages 11-18
|
|
Lack of antitumor activity of recombinant endostatin in a human neuroblastoma xenograft model
a
a
b
a
c
a
a
a
d,e
a
|
|
Author keywords
Angiogenesis; Endostatin; Neuroblastoma; Pharmacokinetics; Recombinant protein
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
COMPLEMENTARY DNA;
ENDOSTATIN;
HYBRID PROTEIN;
RECOMBINANT PROTEIN;
ANGIOGENESIS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL CULTURE;
CANCER INHIBITION;
CAPILLARY ENDOTHELIUM;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG MECHANISM;
ENZYME IMMUNOASSAY;
EXPRESSION VECTOR;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
MALE;
METASTASIS;
MOUSE;
NEUROBLASTOMA;
NONHUMAN;
NUDE MOUSE;
TUMOR VOLUME;
TUMOR XENOGRAFT;
UMBILICAL VEIN;
ANGIOGENESIS INHIBITORS;
ANIMALS;
CATTLE;
COLLAGEN;
ENDOSTATINS;
ESCHERICHIA COLI;
GENE EXPRESSION;
GENES, BACTERIAL;
GENETIC VECTORS;
HUMANS;
MICE;
NEOPLASM TRANSPLANTATION;
NEUROBLASTOMA;
PEPTIDE FRAGMENTS;
RECOMBINANT PROTEINS;
TRANSPLANTATION, HETEROLOGOUS;
TREATMENT FAILURE;
|
|
EID: 0035045114
PISSN: 0167594X
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1006420200626 Document Type: Article |
|
Times cited : (42)
|
|
References (13)
|
